Entry |
|
Name |
Cycloserine (JP18/USP/INN); Seromycin (TN) |
Abbr |
DCS |
Product |
|
Generic |
|
Formula |
C3H6N2O2
|
Exact mass |
102.0429
|
Mol weight |
102.0919
|
Structure |
|
Simcomp |
|
Source |
Streptomyces lavendulae [TAX: 1914], Streptomyces roseochromogenes [TAX: 67357]
|
Class |
Antibacterial
DG01966 Antitubercular
|
Remark |
Therapeutic category: | 6162 |
|
Efficacy |
Antibacterial (tuberculostatic), Cell wall biosynthesis inhibitor |
Disease |
|
Comment |
Natural product
|
Target |
D-alanine-D-alanine ligase [KO: K01921] alanine racemase [KO: K01775] |
Pathway |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J04 ANTIMYCOBACTERIALS
J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
J04AB Antibiotics
J04AB01 Cycloserine
D00877 Cycloserine (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antimycobacterials
Antituberculars
Cycloserine
D00877 Cycloserine (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
61 Antibiotics
616 Acting mainly on acid-fast bacteria
6162 Cycloserines
D00877 Cycloserine (JP18/USP/INN)
Drug groups [BR:br08330]
Antibacterial
DG01966 Antitubercular
D00877 Cycloserine
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, other
Other peptidoglycan biosynthesis inhibitor
D00877 Cycloserine (JP18/USP/INN) <JP/US>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell wall biosynthesis inhibitor, other
Other peptidoglycan biosynthesis inhibitor
D00877 Cycloserine (JP17/USP/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00877 Cycloserine
|
Other DBs |
|
KCF data |
ATOM 7
1 C1x C 7.7000 -17.0800
2 O2x O 9.1000 -17.0800
3 N1x N 9.5326 -15.7485
4 C5x C 8.4000 -14.9256
5 C1y C 7.2674 -15.7485
6 O5x O 8.4000 -13.5100
7 N1a N 5.9478 -15.3197
BOND 7
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 4 6 2
7 5 7 1 #Up
|